› 2xfn

X-ray diffraction
1.6Å resolution

Human monoamine oxidase B in complex with 2-(2-benzofuranyl)-2- imidazoline

Released:
DOI: 10.2210/pdb2xfn/pdb
PDB entry 2xfn coloured by chain, front view.
PDB entry 2xfn coloured by chain, side view.
PDB entry 2xfn coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Potentiation of ligand binding through cooperative effects in monoamine oxidase B.
Bonivento D, Milczek EM, McDonald GR, Binda C, Holt A, Edmondson DE, Mattevi A
J Biol Chem 285 36849-56 (2010)
PMID: 20855894

Function and Biology Details

Reactions catalysed: 
RCH(2)NH(2) + H(2)O + O(2) = RCHO + NH(3) + H(2)O(2)
RCH(2)NHR' + H(2)O + O(2) = RCHO + R'NH(2) + H(2)O(2)
Biochemical function:
Biological process:
Cellular component:
Sequence domains:

Structure analysis Details

Assembly composition:
homo dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-150973 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Amine oxidase [flavin-containing] B Chains: A, B
Molecule details ›
Chains: A, B
Length: 520 amino acids
Theoretical weight: 58.84 KDa
Source organism: Homo sapiens
Expression system: Komagataella pastoris
UniProt:
  • Canonical: P27338 (Residues: 1-520; Coverage: 100%)
Gene name: MAOB
Sequence domains: Flavin containing amine oxidoreductase
Structure domains:

Ligands and Environments


Cofactor: Ligand FAD 2 x FAD
2 bound ligands:
Ligand XCG 2 x XCG
Ligand C15 2 x C15
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: ESRF BEAMLINE ID14-4
Spacegroup: C222
Unit cell:
a: 131.544Å b: 222.445Å c: 86.365Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.166 0.166 0.19
Expression system: Komagataella pastoris

Quick links

Citations

13 review citations

Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release.
Finberg JP. (2014)
12 more

12 mentions without citation

Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders.
Dhiman et al. (2019)
11 more